peripheral arterial disease

Multidisciplinary limb programs offer a cost-effective strategy for managing peripheral arterial disease, particularly in preventing major amputations. Hospitals should evaluate the long-term ROI of such programs, considering reduced readmissions and improv...

A rare case highlights the risk of infected pseudoaneurysm formation following percutaneous closure device use, presenting with a subtle umbilical depression. Early recognition of such subtle signs can prevent significant morbidity and potential mortality.

Patients with iliac occlusive disease face variable outcomes depending on the revascularization technique used. This study highlights potential differences but also underscores the need for more rigorous prospective trials.

Infected pseudoaneurysms following vascular closure device use can lead to significant morbidity. A novel restoration technique addresses the biomechanical flaw contributing to these infections.

Patients facing critical limb ischemia (CLI) often have limited options beyond amputation. A new preclinical study suggests a combined approach of CD34+ cell therapy and hyperbaric oxygen could rejuvenate endothelial progenitor cells, offering a potential p...

Patients with peripheral artery occlusive disease (PAOD) face a high risk of limb amputation when critical ischemia sets in. A new study suggests a combined approach of CD34+ cell therapy and hyperbaric oxygen might rejuvenate endothelial progenitor cells (...

Among patients with peripheral artery disease , multivariable risk modeling identified independent predictors of myocardial infarction , with traditional atherosclerotic factors and markers of PAD severity showing positive associations after adjustment, whi...

In peripheral artery disease , myocardial infarction risk appears concentrated among patients with greater atherothrombotic burden and clinical comorbidities. An analysis characterizes risk signals spanning polyvascular involvement, limb ischemia indices, a...

In peripheral artery disease, the risk of myocardial infarction clusters around clinical burden, vascular physiology, biomarkers, and treatment gaps. An analysis of routinely collected factors delineates higher-risk phenotypes and practical levers for mitig...